Senators cite study showing 22 times higher serious side effects from chemical abortion drugs than FDA labels indicate, ...

UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...

The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...

Somehow, it’s becoming even harder to get a GLP-1.

The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.

The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

The US Food and Drug Administration said Friday that it is taking action to restrict the use of prescription fluoride supplements, following a directive from the government’s Make American Healthy ...

This clearance comes just a few short months after Wandercraft received expanded CE Mark certification for enhanced clinical ...

The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left ...

The FDA has named six new additions to the Commissioner’s National Priority Voucher (CNPV) program, expanding the initiative to 15 products that address critical public health and national security ...

The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from knowing whether medications made overseas are tainted by manufacturing failures.

Let’s be clear: 7-OH is not a public health crisis. According to the Food and Drug Administration’s (FDA) own Adverse Event ...